FHIR © HL7.org  |  FHIRsmith 0.18.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagede.medizininformatikinitiative.kerndatensatz.onkologie
Resource TypeAdverseEvent
IdAdverseEvent-mii-exa-onko-oxaliplatin-neuropathy.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source


English


Generated Narrative: AdverseEvent mii-exa-onko-oxaliplatin-neuropathy

actuality: Adverse Event

event: Oxaliplatin-induced peripheral neuropathy, grade 3 (CTCAE v5.0)

subject: Martin Beispiel Male, DoB: 1958-11-03

date: 2024-06-10

detected: 2024-06-05

recordedDate: 2024-06-10

seriousness: Non-serious

severity: Severe

suspectEntity

instance: MedicationStatement: status = stopped; statusReason = Adverse reaction (disorder); medication[x] = Oxaliplatin; effective[x] = 2024-03-15 --> 2024-06-10; note = FOLFOX4 - Cycles 1-6 only. Discontinued due to severe peripheral neuropathy. Patient experienced numbness and tingling in hands and feet (grade 3 CTCAE), interfering with daily activities.

Causalities

-Assessment
*Certain

German


Generated Narrative: AdverseEvent mii-exa-onko-oxaliplatin-neuropathy

actuality: Adverse Event

event: Oxaliplatin-induced peripheral neuropathy, grade 3 (CTCAE v5.0)

subject: Martin Beispiel Male, DoB: 1958-11-03

date: 2024-06-10

detected: 2024-06-05

recordedDate: 2024-06-10

seriousness: Non-serious

severity: Severe

suspectEntity

instance: MedicationStatement: status = stopped; statusReason = Adverse reaction (disorder); medication[x] = Oxaliplatin; effective[x] = 2024-03-15 --> 2024-06-10; note = FOLFOX4 - Cycles 1-6 only. Discontinued due to severe peripheral neuropathy. Patient experienced numbness and tingling in hands and feet (grade 3 CTCAE), interfering with daily activities.

Causalities

-Assessment
*Certain

Source1

{
  "resourceType": "AdverseEvent",
  "id": "mii-exa-onko-oxaliplatin-neuropathy",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "actuality": "actual",
  "event": {
    "coding": [
      {
        "system": "https://www.meddra.org",
        "code": "10034620",
        "display": "Peripheral sensory neuropathy"
      }
    ],
    "text": "Oxaliplatin-induced peripheral neuropathy, grade 3 (CTCAE v5.0)"
  },
  "subject": {
    "reference": "Patient/example-modification"
  },
  "date": "2024-06-10",
  "detected": "2024-06-05",
  "recordedDate": "2024-06-10",
  "seriousness": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/adverse-event-seriousness",
        "code": "non-serious"
      }
    ]
  },
  "severity": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/adverse-event-severity",
        "code": "severe",
        "display": "Severe"
      }
    ]
  },
  "suspectEntity": [
    {
      "instance": {
        "reference": "MedicationStatement/mii-exa-onko-modification-oxaliplatin-phase1"
      },
      "causality": [
        {
          "assessment": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess",
                "code": "certain",
                "display": "Certain"
              }
            ]
          }
        }
      ]
    }
  ]
}